Evidence map›Paper›PMID 25986014›Full record

ArticleJournal of leukocyte biology2015

NK cells inhibit humoral immunity by reducing the abundance of CD4+ T follicular helper cells during a chronic virus infection.

Kevin D Cook, Hannah C Kline, Jason K Whitmire

Open access · bronzeAbstract read
In one paragraph

Article in Journal of leukocyte biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Unconventional functions of natural killer cells in homeostasis and disease.Journal of immunology (Baltimore, Md. : 1950) · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Observational
  14. Circulating CXCR5Clinical & translational immunology · 2023
    Article
  15. Article
  16. The role of NK cells in rheumatoid arthritis.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2021
    Review
  17. Article
  18. Targeting natural killer cells to enhance vaccine responses.Trends in pharmacological sciences · 2021
    Review
  19. Inflammation, immunity and potential target therapy of SARS-COV-2: A total scale analysis review.Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association · 2021
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Kevin D Cook*Department of Genetics and Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
Hannah C Kline*Department of Genetics and Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
Jason K Whitmire*Department of Genetics and Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA jwhitmir@email.unc.edu.
University of North Carolina at Chapel Hill · US

Funding

BASIC IMMUNE MECHANISMST32AI007273 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI TISCH, ROLAND M · 1985 to 2020
$5.6M
Analyses of the effects of pro-inflammatory cytokines on CD4+ T cell responsesR01AI074862 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI WHITMIRE, JASON KYLE · 2008 to 2012
$1.6M
NK cell regulation of adaptive immunity during persisting virus infectionR56AI110682 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI WHITMIRE, JASON KYLE · 2014 to 2014
$380k
NIAID NIH HHS R01 AI074862NIAID NIH HHS R01AI074862NIAID NIH HHS R56 AI110682NIAID NIH HHS R56AI110682NIAID NIH HHS T32 AI007273NIAID NIH HHS T32AI7273-27
6 · The paper itself

Abstract

There is a need to understand better how to improve B cell responses and immunity to persisting virus infections, which often cause debilitating illness or death. People with chronic virus infection show evidence of improved virus control when there is a strong neutralizing antibody response, and conversely, B cell dysfunction is associated with higher viral loads. We showed previously that NK cells inhibit CD4(+) and CD8(+) T cell responses to disseminating LCMV infection and that depletion of NK cells attenuates chronic infection. Here, we examined the effect of NK cell depletion on B cell responses to LCMV infection in mice. Whereas mice infected acutely generated a peak level of antibody soon after the infection was resolved, mice infected chronically showed a continued increase in antibody levels that exceeded those after acute infection. We found that early NK cell depletion rapidly increased virus-specific antibody levels to chronic infection, and this effect depended on CD4(+) T cells and was associated with elevated numbers of CXCR5(+)CD4(+) TFH cells. However, the NK cell-depleted mice controlled the infection and by 1 mo pi, had lower TFH cell numbers and antibody levels compared with mice with sustained infection. Finally, we show that NK cell depletion improved antiviral CD8(+) T cell responses only when B cells and virus-specific antibody were present. Our data indicate that NK cells diminish immunity to chronic infection, in part, by suppressing TFH cell and antibody responses.

Indexed as

Immunity, HumoralAdaptive ImmunityAnimalsB-LymphocytesCD8-Positive T-LymphocytesDendritic CellsGene Expression RegulationHistocompatibility Antigens Class IHumansInterferon Type IKiller Cells, NaturalLymphocyte ActivationLymphocyte CountLymphocyte DepletionMiceNatural Cytotoxicity Triggering Receptor 1Histocompatibility Antigens Class IInterferon Type INatural Cytotoxicity Triggering Receptor 1NCR1 protein, humanantibodyhost defenseimmune regulationlymphocytic choriomeningitis virusmice

Identifiers

PMID25986014
PMCPMC4763952
OpenAlexW1840106844

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.